1.Early outcomes of robot-assisted subxiphoid approach and intercostal approach for anterior mediastinal tumors: A retrospective cohort study
Weiqiang ZENG ; Haili DANG ; Lifei WANG ; Zhen PENG ; Xiangdou BAI ; Bing WANG ; Xiaoyang HE ; Dacheng JIN ; Yunjiu GOU
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 2026;33(03):369-375
Objective To compare the clinical outcomes of subxiphoid robot-assisted thoracoscopic surgery (SRATS) and intercostal robot-assisted thoracoscopic surgery (IRATS) in the treatment of anterior mediastinal tumors. Methods A retrospective analysis was conducted on patients with anterior mediastinal tumors who underwent robot-assisted surgery in the Department of Thoracic Surgery, Gansu Provincial Hospital, from May 2020 to July 2022. According to the surgical approach, patients were divided into an SRATS group and an IRATS group. Perioperative data were compared between the two groups. Results A total of 87 patients were included. There were 41 patients in the SRATS group [23 males, 18 females; mean age, (44.51±11.28) years] and 46 patients in the IRATS group [21 males, 25 females; mean age, (46.67±8.76) years]. Compared with the IRATS group, the SRATS group had significantly less intraoperative blood loss [(24.41±6.67) mL vs. (37.93±9.23) mL, P<0.001], shorter postoperative drainage duration [(1.73±0.59) days vs. (2.54±0.50) days, P<0.001], lower postoperative drainage volume [(94.46±34.08) mLvs. (116.72±24.90) mL, P=0.001], lower visual analogue scale (VAS) pain scores on postoperative day 1 [(3.66±0.76) points vs. (4.15±0.84) points, P=0.005] and day 3 [(2.41±0.59) points vs. (2.89±0.82) points, P=0.003], shorter postoperative hospital stay [(4.12±0.81) days vs. (4.98±1.02) days, P<0.001], and lower hospitalization costs [(4.51±0.65) ten thousand yuan vs. (4.86±0.68) ten thousand yuan, P=0.020]. There were no statistical differences between the two groups in operative time or incidence of postoperative complications (P>0.05). Conclusion Both SRATS and IRATS are safe and effective for the treatment of anterior mediastinal tumors. However, SRATS is less invasive and more conducive to enhanced postoperative recovery.
2.Research progress on the mechanisms linking and intervention of adolescent depression and lipid metabolism disorders
Ruhui LI ; Jianfei ZENG ; Bing WANG ; Qin WANG ; Ying ZHANG
Sichuan Mental Health 2026;39(2):175-182
In recent years, the incidence of depression among adolescents has increased significantly, becoming a serious global public health problem. There is a close relationship between adolescent depression and lipid metabolism abnormalities. However, the mechanisms underlying this association have not been fully elucidated. This article provides a review of the mechanisms and interventions linking adolescent depression and lipid metabolism abnormalities, aiming to offer new ideas for interventions in adolescent depression. Using computerized searches of the China National Knowledge Infrastructure (CNKI), Wanfang Data, PubMed, and Web of Science, studies on the mechanisms and interventions related to adolescent depression and lipid metabolism were collected, with the search period extending up to October 10, 2025. Two researchers independently conducted literature screening and extracted basic information from the included studies. A total of 12 original studies were included. The results indicate that adolescent depression is associated with certain lipid metabolites. Neurobiological factors, immune inflammation, oxidative stress, and gut microbiota imbalance play important roles in this association. In addition, lipid metabolites such as omega-3 polyunsaturated fatty acids (ω-3 PUFAs) have a significant ameliorating effect on adolescent depression. [Funded by Shenzhen Fund for Guangdong Provincial High-level Clinical Key Specialties (number, SZGSP013); Shenzhen Science and Technology Program (number, 20210617155253001)]
3.Response to Comments on “Pretreatment 68Ga-PSMA-11 PET/CT to Predict the Response to Treatment With Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors in Patients With Metastatic Renal Cell Carcinoma”
Shao-Hao CHEN ; Xiao-Hui WU ; Qian-Ren-Shun QIU ; Shao-Ming CHEN ; Jie ZANG ; Jun-Ming ZHU ; Cheng-Long ZENG ; Wei-Bing MIAO ; Xue-Yi XUE ; Ning XU
Korean Journal of Radiology 2026;27(2):188-190
4.Quality of life among vocational rehabilitation patients with mild work-related disability and its association with return-to-work outcomes
Huiling ZHOU ; Jiayan ZENG ; Bing CHEN
Chinese Journal of Rehabilitation Theory and Practice 2026;32(9):1078-1086
ObjectiveTo explore the impact of comprehensive vocational rehabilitation on quality of life and return-to-work outcomes for individuals with mild work-related disability. MethodsA longitudinal observational study was conducted. A total of 343 work-injured employees receiving comprehensive vocational rehabilitation intervention in Guangdong Work Injury Rehabilitation Hospital from June, 2023 to December, 2024 were selected. The 36-item Short Form Health Survey (SF-36) was adopted to assess their health-related quality of life at admission and discharge. All subjects were followed up within one year after discharge to collect their return-to-work status. The differences in each dimension score of SF-36 among patients with different return-to-work outcomes (return to original post, transfer to new post and non-return to work) were compared, and the independent influencing factors of return-to-work outcomes were identified. ResultsComprehensive vocational rehabilitation intervention significantly improved the scores of physical functioning (PF), role-physical (RP) and role-emotional (RE) among work-injured employees (P < 0.05). At discharge, compared with patients who failed to return to work, patients returning to original post obtained significantly higher scores in PF, RP, bodily pain (BP), general health (GH), vitality (VT), social functioning (SF) and mental health (MH), patients transferred to new post achieved significantly higher scores in PF, BP, GH and SF (P < 0.05). Taking non-return-to-work status as the reference category, the multinomial logistic regression model showed the adverse factors for return to original post included low educational attainment (college diploma or below), on-site placement service, increased lost workdays and low employment intention (pre-contemplation and contemplation stages); the protective factor was positive evaluation of health transition (HT); for patients transferred to new posts, adverse factors were low employment intention (pre-contemplation stage) and increased lost workdays, while protective factors covered on-site placement service and positive HT evaluation. ConclusionComprehensive vocational rehabilitation can improve the quality of life for injured workers. Better quality of life is positively associated with return-to-work outcomes. HT, education level, job placement mode, lost workdays and employment willingness are independent factors impacting return-to-work outcomes.
5.Analysis of the Theory of "Spirit Turns but Does Not Reverse;If It Reverses,It Ceases to Turn" in The Inner Canon of Yellow Emperor (《黄帝内经》) and Its Clinical Significance
Bin PENG ; Wenyi LUO ; Bing LI ; Shengxing WANG ; Ziling ZENG ; Lin TONG ; Huamin ZHANG
Journal of Traditional Chinese Medicine 2026;67(19):2139-2143
"Spirit turns but does not reverse; if it reverses, it ceases to turn" originates from the Plain Questions: Discussion on Essential Jade Plates (《素问·玉版论要篇》). It profoundly summarizes the objectivity of life as a phenomenon subject to the laws of the universe and nature, while also expressing the subjectivity of individuals possessing systematic, stable, and ordered biological rhythms. In light of relevant ancient philosophical insights, the theory of "spirit turns but does not reverse; if it reverses, it ceases to turn" embodies the principles of constant motion in life, change according to dao (道), orderly progression, and the rule that reversal disrupts continuity. In clinical diagnosis and treatment, one should adopt the therapeutic principle of regulating spirit to promote "spirit turning". Guiding along the trend and acting in accordance with the natural momentum must be adopted to maintain the operation of spirit turning. Adhering to constancy while recognizing variability, and prioritizing harmony above all, should be employed to ensure the orderly progress of spirit turning. Regulating qi movement serves as the driving force behind facilitating spirit turning. This will provide clinical insights and theoretical foundations for treating diseases through the concept of "regulating spirit".
6.Analysis of the Theory of "Spirit Turns but Does Not Reverse;If It Reverses,It Ceases to Turn" in The Inner Canon of Yellow Emperor (《黄帝内经》) and Its Clinical Significance
Bin PENG ; Wenyi LUO ; Bing LI ; Shengxing WANG ; Ziling ZENG ; Lin TONG ; Huamin ZHANG
Journal of Traditional Chinese Medicine 2026;67(19):2139-2143
"Spirit turns but does not reverse; if it reverses, it ceases to turn" originates from the Plain Questions: Discussion on Essential Jade Plates (《素问·玉版论要篇》). It profoundly summarizes the objectivity of life as a phenomenon subject to the laws of the universe and nature, while also expressing the subjectivity of individuals possessing systematic, stable, and ordered biological rhythms. In light of relevant ancient philosophical insights, the theory of "spirit turns but does not reverse; if it reverses, it ceases to turn" embodies the principles of constant motion in life, change according to dao (道), orderly progression, and the rule that reversal disrupts continuity. In clinical diagnosis and treatment, one should adopt the therapeutic principle of regulating spirit to promote "spirit turning". Guiding along the trend and acting in accordance with the natural momentum must be adopted to maintain the operation of spirit turning. Adhering to constancy while recognizing variability, and prioritizing harmony above all, should be employed to ensure the orderly progress of spirit turning. Regulating qi movement serves as the driving force behind facilitating spirit turning. This will provide clinical insights and theoretical foundations for treating diseases through the concept of "regulating spirit".
7.Effect of Kangxian Yixin Prescription on Cardiac Function and Myocardial Fibroblasts in Dilated Cardiomyopathy Rats
Chuiyi ZENG ; Zhentao WANG ; Huichao ZHANG ; Hongbo CHANG ; Bing WANG ; Suting GU ; Shujuan ZHANG
Chinese Journal of Experimental Traditional Medical Formulae 2026;32(21):86-98
ObjectiveTo investigate the mechanism by which Kangxian Yixin prescription regulates the circular RNA 0006719 (circ0006719)/microRNA 6852-5p (miR-6852-5p)/transforming growth factor-β1 (TGF-β1)/Smad axis to ameliorate myocardial fibrosis in rats with dilated cardiomyopathy (DCM) and angiotensin Ⅱ (Ang Ⅱ)-induced activation of cardiac fibroblasts (CFs). MethodsA DCM rat model was established by administration of furazolidone. The rats were divided into normal group, model group, captopril (CAP, 10.1 mg·kg-1·d-1) group, and low-, medium-, and high-dose Kangxian Yixin prescription groups (0.9, 1.8, 3.6 g·kg-1·d-1), with 15 rats in each group. After modeling, the treatment groups received corresponding drug solutions by gavage, whereas the normal and model groups received an equal volume of normal saline for 60 consecutive days. Echocardiography was used to measure left ventricular end-systolic diameter (LVESD), left ventricular end-diastolic diameter (LVEDD), left ventricular ejection fraction (LVEF), and left ventricular fractional shortening (LVFS). Transmission electron microscopy (TEM), hematoxylin-eosin (HE) staining, and Masson staining were used to observe myocardial ultrastructure, pathological changes, and collagen deposition. Immunohistochemistry (IHC) was used to detect the protein expression of collagen type Ⅰ alpha 1 (Col1A1) and collagen type Ⅲ(Col Ⅲ) in myocardial tissue. Real-time quantitative polymerase chain reaction (Real-time PCR), Western blot, and fluorescence in situ hybridization (FISH) were used to detect the expression and localization of circ0006719, miR-6852-5p, fibrosis-related molecules, and TGF-β1/Smad pathway-related molecules in myocardial tissue and CFs. CFs from neonatal rats were isolated and cultured in vitro. Cell Counting Kit-8 (CCK-8) assay was used to determine the optimal concentration of Kangxian Yixin prescription for subsequent intervention. An Ang Ⅱ-induced CF activation model was established, and the cells were divided into normal group, Ang Ⅱ group, Ang Ⅱ+CAP group, Ang Ⅱ+Kangxian Yixin prescription group, and Ang Ⅱ+Kangxian Yixin prescription+miR-6852-5p inhibitor group. CF viability and fibrosis-related molecular expression were detected. RNA immunoprecipitation (RNA IP) and dual-luciferase reporter assays were used to verify the targeting relationship between circ0006719 and miR-6852-5p. ResultsCompared with the normal group, the model group showed significantly increased LVESD and LVEDD, significantly decreased LVEF and LVFS, aggravated myocardial ultrastructural and histopathological injury, and significantly increased collagen volume fraction (CVF) in myocardial tissue (P<0.01). The expression of circ0006719, Col1A1 mRNA, Col ⅢmRNA, and Col1A1, Col Ⅲ, TGF-β1, Smad3, and Smad4 proteins in myocardial tissue was significantly upregulated, whereas miR-6852-5p expression and Smad7 protein expression were significantly downregulated (P<0.01). Compared with the model group, the CAP group and the high- and medium-dose Kangxian Yixin prescription groups showed varying degrees of improvement in cardiac function, myocardial fibrosis, circ0006719/miR-6852-5p expression, and TGF-β1/Smad pathway-related indicators, with more pronounced improvements in the CAP group and the high-dose Kangxian Yixin prescription group (P<0.05, P<0.01). In in vitro experiments, 2.0 g·L-1 was determined as the optimal concentration of Kangxian Yixin prescription for subsequent intervention. Compared with the normal group, the Ang Ⅱ group showed significantly increased CF viability, significantly upregulated expression of circ0006719, Col1A1 mRNA, α-smooth muscle actin (α-SMA) mRNA, and Col1A1, α-SMA, TGF-β1, Smad3, and Smad4 proteins in CFs, and significantly downregulated miR-6852-5p expression and Smad7 protein expression (P<0.01). Compared with the Ang Ⅱ group, the Ang Ⅱ+CAP group and the Ang Ⅱ+Kangxian Yixin prescription group showed markedly decreased CF viability and fibrosis-related mRNA and protein expression, markedly increased miR-6852-5p expression, and markedly attenuated TGF-β1/Smad pathway activation (P<0.05, P<0.01). Compared with the Ang Ⅱ+Kangxian Yixin prescription group, the Ang Ⅱ+Kangxian Yixin prescription+miR-6852-5p inhibitor group showed significantly increased CF viability (P<0.01), markedly increased expression of circ0006719, Col1A1 mRNA, and Col1A1, TGF-β1, and Smad4 proteins in CFs, and markedly decreased miR-6852-5p expression (P<0.05, P<0.01). RNA IP and dual-luciferase reporter assays showed a targeting binding relationship between circ0006719 and miR-6852-5p (P<0.01). ConclusionKangxian Yixin prescription may alleviate myocardial collagen deposition and myocardial fibrosis, improve cardiac function in DCM rats, and inhibit Ang Ⅱ-induced abnormal activation of CFs. Its mechanism may be associated with downregulation of circ0006719, restoration of miR-6852-5p expression, and inhibition of the TGF-β1/Smad pathway.
8.Effect of Kangxian Yixin Prescription on Cardiac Function and Myocardial Fibroblasts in Dilated Cardiomyopathy Rats
Chuiyi ZENG ; Zhentao WANG ; Huichao ZHANG ; Hongbo CHANG ; Bing WANG ; Suting GU ; Shujuan ZHANG
Chinese Journal of Experimental Traditional Medical Formulae 2026;32(21):86-98
ObjectiveTo investigate the mechanism by which Kangxian Yixin prescription regulates the circular RNA 0006719 (circ0006719)/microRNA 6852-5p (miR-6852-5p)/transforming growth factor-β1 (TGF-β1)/Smad axis to ameliorate myocardial fibrosis in rats with dilated cardiomyopathy (DCM) and angiotensin Ⅱ (Ang Ⅱ)-induced activation of cardiac fibroblasts (CFs). MethodsA DCM rat model was established by administration of furazolidone. The rats were divided into normal group, model group, captopril (CAP, 10.1 mg·kg-1·d-1) group, and low-, medium-, and high-dose Kangxian Yixin prescription groups (0.9, 1.8, 3.6 g·kg-1·d-1), with 15 rats in each group. After modeling, the treatment groups received corresponding drug solutions by gavage, whereas the normal and model groups received an equal volume of normal saline for 60 consecutive days. Echocardiography was used to measure left ventricular end-systolic diameter (LVESD), left ventricular end-diastolic diameter (LVEDD), left ventricular ejection fraction (LVEF), and left ventricular fractional shortening (LVFS). Transmission electron microscopy (TEM), hematoxylin-eosin (HE) staining, and Masson staining were used to observe myocardial ultrastructure, pathological changes, and collagen deposition. Immunohistochemistry (IHC) was used to detect the protein expression of collagen type Ⅰ alpha 1 (Col1A1) and collagen type Ⅲ(Col Ⅲ) in myocardial tissue. Real-time quantitative polymerase chain reaction (Real-time PCR), Western blot, and fluorescence in situ hybridization (FISH) were used to detect the expression and localization of circ0006719, miR-6852-5p, fibrosis-related molecules, and TGF-β1/Smad pathway-related molecules in myocardial tissue and CFs. CFs from neonatal rats were isolated and cultured in vitro. Cell Counting Kit-8 (CCK-8) assay was used to determine the optimal concentration of Kangxian Yixin prescription for subsequent intervention. An Ang Ⅱ-induced CF activation model was established, and the cells were divided into normal group, Ang Ⅱ group, Ang Ⅱ+CAP group, Ang Ⅱ+Kangxian Yixin prescription group, and Ang Ⅱ+Kangxian Yixin prescription+miR-6852-5p inhibitor group. CF viability and fibrosis-related molecular expression were detected. RNA immunoprecipitation (RNA IP) and dual-luciferase reporter assays were used to verify the targeting relationship between circ0006719 and miR-6852-5p. ResultsCompared with the normal group, the model group showed significantly increased LVESD and LVEDD, significantly decreased LVEF and LVFS, aggravated myocardial ultrastructural and histopathological injury, and significantly increased collagen volume fraction (CVF) in myocardial tissue (P<0.01). The expression of circ0006719, Col1A1 mRNA, Col ⅢmRNA, and Col1A1, Col Ⅲ, TGF-β1, Smad3, and Smad4 proteins in myocardial tissue was significantly upregulated, whereas miR-6852-5p expression and Smad7 protein expression were significantly downregulated (P<0.01). Compared with the model group, the CAP group and the high- and medium-dose Kangxian Yixin prescription groups showed varying degrees of improvement in cardiac function, myocardial fibrosis, circ0006719/miR-6852-5p expression, and TGF-β1/Smad pathway-related indicators, with more pronounced improvements in the CAP group and the high-dose Kangxian Yixin prescription group (P<0.05, P<0.01). In in vitro experiments, 2.0 g·L-1 was determined as the optimal concentration of Kangxian Yixin prescription for subsequent intervention. Compared with the normal group, the Ang Ⅱ group showed significantly increased CF viability, significantly upregulated expression of circ0006719, Col1A1 mRNA, α-smooth muscle actin (α-SMA) mRNA, and Col1A1, α-SMA, TGF-β1, Smad3, and Smad4 proteins in CFs, and significantly downregulated miR-6852-5p expression and Smad7 protein expression (P<0.01). Compared with the Ang Ⅱ group, the Ang Ⅱ+CAP group and the Ang Ⅱ+Kangxian Yixin prescription group showed markedly decreased CF viability and fibrosis-related mRNA and protein expression, markedly increased miR-6852-5p expression, and markedly attenuated TGF-β1/Smad pathway activation (P<0.05, P<0.01). Compared with the Ang Ⅱ+Kangxian Yixin prescription group, the Ang Ⅱ+Kangxian Yixin prescription+miR-6852-5p inhibitor group showed significantly increased CF viability (P<0.01), markedly increased expression of circ0006719, Col1A1 mRNA, and Col1A1, TGF-β1, and Smad4 proteins in CFs, and markedly decreased miR-6852-5p expression (P<0.05, P<0.01). RNA IP and dual-luciferase reporter assays showed a targeting binding relationship between circ0006719 and miR-6852-5p (P<0.01). ConclusionKangxian Yixin prescription may alleviate myocardial collagen deposition and myocardial fibrosis, improve cardiac function in DCM rats, and inhibit Ang Ⅱ-induced abnormal activation of CFs. Its mechanism may be associated with downregulation of circ0006719, restoration of miR-6852-5p expression, and inhibition of the TGF-β1/Smad pathway.
9.Interpretation on the multiple connotations of twelve-meridian differentiation.
Huilin ZENG ; Bing LIU ; Ruixia WANG
Chinese Acupuncture & Moxibustion 2025;45(9):1341-1346
It attempts to determine the theoretical connotation and clinical application of the twelve-meridian based syndrome/pattern differentiation of TCM through the systematic analysis and elaboration, so as to promote the completion of meridian differentiation system. The exploration is conducted on the main body of traditional meridian-syndrome differentiation, meaning the meridian differentiation in terms of location of illness and that in terms of symptoms. The existing problems and causes are analyzed, and the specific methods of meridian differentiation put forward in line with the characteristics of meridian distribution and symptoms. In reference with Huangdi Neijing (Yellow Emperors' Canon of Medicine) and other ancient literature, the theoretical evidences of meridian differentiation are deeply analyzed in view of physiological/pathological characteristics that has been neglected in the past, such as qi and blood of meridians, opening, closing and pivoting, and time. Additionally, the category issues related to twelve-meridian differentiation and their relationship with six-meridian differentiation are expounded. The summary on the multiple connotations of twelve-meridian differentiation is of great significance on re-understanding meridians, perfecting meridian-collateral differentiation system and improving the accuracy on meridian-based treatment. Besides, the reconstruction of meridian differentiation and its framework is considered profoundly.
Meridians
;
Humans
;
Medicine, Chinese Traditional
;
Acupuncture Therapy
;
Diagnosis, Differential
;
History, Ancient
;
Acupuncture Points
;
Medicine in Literature
10.Mechanism of Euphorbiae Ebracteolatae Radix processed by milk in reducing intestinal toxicity.
Chang-Li SHEN ; Hao WU ; Hong-Li YU ; Hong-Mei WEN ; Xiao-Bing CUI ; Hui-Min BIAN ; Tong-la-Ga LI ; Min ZENG ; Yan-Qing XU ; Yu-Xin GU
China Journal of Chinese Materia Medica 2025;50(12):3204-3213
This study aimed to investigate the correlation between changes in intestinal toxicity and compositional alterations of Euphorbiae Ebracteolatae Radix(commonly known as Langdu) before and after milk processing, and to explore the detoxification mechanism of milk processing. Mice were intragastrically administered the 95% ethanol extract of raw Euphorbiae Ebracteolatae Radix, milk-decocted(milk-processed), and water-decocted(water-processed) Euphorbiae Ebracteolatae Radix. Fecal morphology, fecal water content, and the release levels of inflammatory cytokines tumor necrosis factor-α(TNF-α) and interleukin-1β(IL-1β) in different intestinal segments were used as indicators to evaluate the effects of different processing methods on the cathartic effect and intestinal inflammatory toxicity of Euphorbiae Ebracteolatae Radix. LC-MS/MS was employed to analyze the small-molecule components in the raw product, the 95% ethanol extract of the milk-processed product, and the milky waste(precipitate) formed during milk processing, to assess the impact of milk processing on the chemical composition of Euphorbiae Ebracteolatae Radix. The results showed that compared with the blank group, both the raw and water-processed Euphorbiae Ebracteolatae Radix significantly increased the fecal morphology score, fecal water content, and the release levels of TNF-α and IL-1β in various intestinal segments(P<0.05). Compared with the raw group, all indicators in the milk-processed group significantly decreased(P<0.05), while no significant differences were observed in the water-processed group, indicating that milk, as an adjuvant in processing, plays a key role in reducing the intestinal toxicity of Euphorbiae Ebracteolatae Radix. Mass spectrometry results revealed that 29 components were identified in the raw product, including 28 terpenoids and 1 acetophenone. The content of these components decreased to varying extents after milk processing. A total of 28 components derived from Euphorbiae Ebracteolatae Radix were identified in the milky precipitate, of which 27 were terpenoids, suggesting that milk processing promotes the transfer of toxic components from Euphorbiae Ebracteolatae Radix into milk. To further investigate the effect of milk adjuvant processing on the toxic terpenoid components of Euphorbiae Ebracteolatae Radix, transmission electron microscopy(TEM) was used to observe the morphology of self-assembled casein micelles(the main protein in milk) in the milky precipitate. The micelles formed in casein-terpenoid solutions were characterized using particle size analysis, fluorescence spectroscopy, ultraviolet spectroscopy, and Fourier-transform infrared(FTIR) spectroscopy. TEM observations confirmed the presence of casein micelles in the milky precipitate. Characterization results showed that with increasing concentrations of toxic terpenoids, the average particle size of casein micelles increased, fluorescence intensity of the solution decreased, the maximum absorption wavelength in the UV spectrum shifted, and significant changes occurred in the infrared spectrum, indicating that interactions occurred between casein micelles and toxic terpenoid components. These findings indicate that the cathartic effect of Euphorbiae Ebracteolatae Radix becomes milder and its intestinal inflammatory toxicity is reduced after milk processing. The detoxification mechanism is that terpenoid components in Euphorbiae Ebracteolatae Radix reassemble with casein in milk to form micelles, promoting the transfer of some terpenoids into the milky precipitate.
Animals
;
Mice
;
Milk/chemistry*
;
Drugs, Chinese Herbal/chemistry*
;
Male
;
Tumor Necrosis Factor-alpha/immunology*
;
Intestines/drug effects*
;
Interleukin-1beta/immunology*
;
Tandem Mass Spectrometry
;
Female

Result Analysis
Print
Save
E-mail